|
ERNA Ernexa Therapeutics Inc 748592 |
| Balance Sheet |
|
Current Assets
|
$5,894,000.00 |
|
Assets
|
$6,315,000.00 |
|
Current Liabilities
|
$2,932,000.00 |
|
Liabilities
|
$3,115,000.00 |
|
Equity
|
$3,200,000.00 |
|
Shares Out
|
1170000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,416,000.00 |
|
Investing Cash Flow
|
$-5,000.00 |
| Market Analysis |
Market Cap
|
$5,288,400.00 |
|
Price
|
$4.52 |
|
BVPS
|
2.74 |
|
PB
|
1.65 |
|
EPS
|
-3.40 |
|
PS
|
9.09 |
|
FCF
|
$-6,421,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ERNA documents filed with the SEC.
ERNA Filings
Clear
